The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss.
Breakdown
- Novo Nordisk has cut the price of Ozempic for some patients.
- The price reduction targets patients with type 2 diabetes who lack insurance. 38s
- Eli Lilly is increasing competition with lower-priced drugs and strong supply. 26s
- A study found Eli Lilly's drug led to greater weight loss than Novo Nordisk's. 1m 5s
- Health improvements were proportional to the amount of weight lost. 1m 18s